These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
239 related articles for article (PubMed ID: 1847351)
1. Regulation of insulin-like growth factor II gene expression by hepatitis B virus in hepatocellular carcinoma. d'Arville CN; Nouri-Aria KT; Johnson P; Williams R Hepatology; 1991 Feb; 13(2):310-5. PubMed ID: 1847351 [TBL] [Abstract][Full Text] [Related]
2. Activation of fetal promoters of insulinlike growth factors II gene in hepatitis C virus-related chronic hepatitis, cirrhosis, and hepatocellular carcinoma. Nardone G; Romano M; CalabrĂ² A; Pedone PV; de Sio I; Persico M; Budillon G; Bruni CB; Riccio A; Zarrilli R Hepatology; 1996 Jun; 23(6):1304-12. PubMed ID: 8675143 [TBL] [Abstract][Full Text] [Related]
3. Expression of insulin-like growth factor II in chronic hepatitis B, liver cirrhosis, and hepatocellular carcinoma. Seo JH; Park BC Gan To Kagaku Ryoho; 1995 Aug; 22 Suppl 3():292-307. PubMed ID: 7661600 [TBL] [Abstract][Full Text] [Related]
4. [Significance and expression of insulin-like growth factor II and its receptor in hepatocellular carcinogenesis]. Fan Z; Yang D; Qin H Zhonghua Gan Zang Bing Za Zhi; 2000 Apr; 8(2):84-6. PubMed ID: 10861110 [TBL] [Abstract][Full Text] [Related]
6. Expression of insulin-like growth factor II, alpha-fetoprotein and hepatitis B virus transcripts in human primary liver cancer. Cariani E; Lasserre C; Kemeny F; Franco D; Brechot C Hepatology; 1991 Apr; 13(4):644-9. PubMed ID: 1707028 [TBL] [Abstract][Full Text] [Related]
7. Increased expression of insulin-like growth factor 2 in hepatocellular carcinoma is primarily regulated at the transcriptional level. Sohda T; Yun K; Iwata K; Soejima H; Okumura M Lab Invest; 1996 Sep; 75(3):307-11. PubMed ID: 8804354 [TBL] [Abstract][Full Text] [Related]
8. The human hepatitis B virus transactivator X gene product regulates Sp1 mediated transcription of an insulin-like growth factor II promoter 4. Lee YI; Lee S; Lee Y; Bong YS; Hyun SW; Yoo YD; Kim SJ; Kim YW; Poo HR Oncogene; 1998 May; 16(18):2367-80. PubMed ID: 9620554 [TBL] [Abstract][Full Text] [Related]
9. [The significance and promoter expression of insulin-like growth factor-II gene in human hepatocellular carcinoma]. Tang SH; Yang DH; Huang W; Zhou M; Zhou HK; Lu XH; Ye G Zhonghua Gan Zang Bing Za Zhi; 2006 Jun; 14(6):456-8. PubMed ID: 16792873 [No Abstract] [Full Text] [Related]
10. Increased expression of the insulin-like growth factor I (IGF-I) receptor gene in hepatocellular carcinoma cell lines: implications of IGF-I receptor gene activation by hepatitis B virus X gene product. Kim SO; Park JG; Lee YI Cancer Res; 1996 Aug; 56(16):3831-6. PubMed ID: 8706031 [TBL] [Abstract][Full Text] [Related]
11. Genetic changes and expression of the mannose 6-phosphate/insulin-like growth factor II receptor gene in human hepatitis B virus-associated hepatocellular carcinoma. Yang EB; Qin LL; Zhao YN; Zhang K; Chow P Int J Mol Med; 2003 Jun; 11(6):773-8. PubMed ID: 12736721 [TBL] [Abstract][Full Text] [Related]
12. Transcripts of the insulin-like growth factors I and II in human hepatoma. Su TS; Liu WY; Han SH; Jansen M; Yang-Fen TL; P'eng FK; Chou CK Cancer Res; 1989 Apr; 49(7):1773-7. PubMed ID: 2466561 [TBL] [Abstract][Full Text] [Related]
13. [Early diagnostic value of abnormal expression of insulin-like growth factor (IGF)-II and IGF-II-mRNA in hepatocellular carcinoma patients]. Dong ZZ; Yao DF; Wu XH; Shi GS; Qiu LW; Wu W; Su XQ Zhonghua Gan Zang Bing Za Zhi; 2005 Nov; 13(11):866-8. PubMed ID: 16313745 [No Abstract] [Full Text] [Related]
14. Immunohistochemical expression of CD95 (Fas), c-myc and epidermal growth factor receptor in hepatitis C virus infection, cirrhotic liver disease and hepatocellular carcinoma. El-Bassiouni A; Nosseir M; Zoheiry M; El-Ahwany E; Ghali A; El-Bassiouni N APMIS; 2006 Jun; 114(6):420-7. PubMed ID: 16856963 [TBL] [Abstract][Full Text] [Related]
15. Hypomethylated P4 promoter induces expression of the insulin-like growth factor-II gene in hepatocellular carcinoma in a Chinese population. Tang SH; Yang DH; Huang W; Zhou HK; Lu XH; Ye G Clin Cancer Res; 2006 Jul; 12(14 Pt 1):4171-7. PubMed ID: 16857788 [TBL] [Abstract][Full Text] [Related]
16. Changes in the antioxidant defense and hepatic drug metabolizing enzyme and isoenzyme levels, 8-hydroxydeoxyguanosine formation and expressions of c-raf.1 and insulin-like growth factor II genes during the stages of development of hepatocellular carcinoma in rats. Mukherjee B; Das T; Ghosh S; Datta S Eur J Cancer Prev; 2007 Aug; 16(4):363-71. PubMed ID: 17554210 [TBL] [Abstract][Full Text] [Related]
17. Expression profile of nine novel genes differentially expressed in hepatitis B virus-associated hepatocellular carcinomas. Kim MY; Park E; Park JH; Park DH; Moon WS; Cho BH; Shin HS; Kim DG Oncogene; 2001 Jul; 20(33):4568-75. PubMed ID: 11494152 [TBL] [Abstract][Full Text] [Related]
18. Molecular profiling of human hepatocellular carcinoma defines mutually exclusive interferon regulation and insulin-like growth factor II overexpression. Breuhahn K; Vreden S; Haddad R; Beckebaum S; Stippel D; Flemming P; Nussbaum T; Caselmann WH; Haab BB; Schirmacher P Cancer Res; 2004 Sep; 64(17):6058-64. PubMed ID: 15342387 [TBL] [Abstract][Full Text] [Related]
19. Expression of insulin-like growth factor II in hepatitis B, cirrhosis and hepatocellular carcinoma: its relationship with hepatitis B virus antigen expression. Su Q; Liu YF; Zhang JF; Zhang SX; Li DF; Yang JJ Hepatology; 1994 Oct; 20(4 Pt 1):788-99. PubMed ID: 7927218 [TBL] [Abstract][Full Text] [Related]
20. Insulin-like growth factor II induced by hypoxia may contribute to angiogenesis of human hepatocellular carcinoma. Kim KW; Bae SK; Lee OH; Bae MH; Lee MJ; Park BC Cancer Res; 1998 Jan; 58(2):348-51. PubMed ID: 9443416 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]